Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PCM Exam 4 > Antidiabetic Drugs 2 > Flashcards

Antidiabetic Drugs 2 Flashcards

1
Q

chlorpropamide is a ___ generation sulfonylureas; what are some AE’s?

A

1st; has a long half life: hypoglycemia, hyperemic flush when dirt k alcohol and can potentiate action of vasopressin leading to SIADH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the effects of glucagon on:
cardiac ionotropy and chronotropy
intestine

A
  • ↑ cardiac ionotropy and chronotropy

- relaxes the intestine (in large doses)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

a typical regiment for managing diabetes in a pregnant patient tarot with a single dose of bedtime _______

A

NPH insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

meglitindies are _____ (time) glucose regulators

A

postprandial; because these have a rapid onset and short duration of action so take them before each meal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

both sufonuylureas and meglitinides have the same MOA. what is the difference and which one is more effective?

A
  • meglitinides (repaglinide and nateglinide) hae sorter half life but are NOT AS EFFECTIVE in reducing fasting plasma glucose and HBA1c

meglitinides do not have sulfur and thus can be indicated in patients with sulfur allergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

colesevelam is a bile acid sequestrant used to lower ______

A

LDL cholesterol; give to type 2 DM patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are some scenarios you would give a diabetic patient statins?

A

should be given REGARDLESS OF LIPID LEVELS:

  • patients with CVD
  • younger than 40 with CVD risk factors
  • older than 40 w/ or w/o CVD risk factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

a patient with type 2 DM tried to change lifestyle but his HBA1c levels did not improve. Doctor prescribes metformin but the levels did not lower by 1%. so he starts a dual combination therapy. What drugs would he prescribe?

A

oral agent, exenatide (injectable) or insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what type of patient is metformin contraindicated in?

A

those that are more prone to lactic acidosis:

  • renal disease
  • hepatic disease
  • hypoxia
  • alcoholism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is the MOA of canagliflozin to treat diabetes?

A
  • inhibits SGLT-2 and thus ↓ the reabsorption of glucose BUT because there is more glucose in the urinary tract, users of this drug are at more risk for UTI’s
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

pramlintide is an analog of _______

A

amylin;
amylin is a peptide that is co-secreted with insulin from β cells and it inhibits food intake, gastric emptying and glucagon secretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are two drugs that can cause pancreatitis?

A
  • exenatide

- sitagliptin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is the MOA and effect of acarbose?

A
  • it reduces post prandial digestion of starch and carbohydrates in the upper intestine (↓ post prandial hyperglycemia and hyperinsulinemia)
  • acarbose is a competitive inhibitor to the enzyme α glucosidase with converts disaccharides and trisaccharides to glucose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

a diabetic patient presents with albuminuria. what drug would you give them in addition to what they are taking

A

ACEI or ARB’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

______ therapy should be given as a primary prevention statregy in patient with diebaes and an ↑ cardiovascular risk

A

low dose aspirin because it is an anti platelet agent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

of the 2nd generation sulfonylreuas, which one is most likely to cause hypoglycemia? which one is least likely?

A

most likely to see hypoglycemia: glyburide

least likely to see hypoglycemia: glipizide (short half life)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

any patient placed on ______ (diabetic drug) MUST be placed on liver function monitoring

A

TZD (glitazones) specifically troglitazone because it can cause severe hepatic toxicity (not seen with pioglitazone or rosiglitazone)
also with acarbose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

when is a good time to use metformin?

A

insulin resistant patients because metformin does not cause secretion of insulin but rather ↓ gene expression of gluconoegenic enzymes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

_______ is a drug that affects gene expression as part of its MOA in treating diabetes via activation of AMP activated protein kinase

A

metformin

20
Q

weight loss/gain is an AE of metformin

A

weight loss;

with drugs that cause insulin secretion, the AE would be weight gain because insulin is anabolic

21
Q

glucose is filtered by the glomerulus and reabsorbed in the proximal tubule by which transporters?

A

SGLT’s (sodium glucose linked transporter)

22
Q

thiazolidinediones (TZDs) are used to ________ by ________

A

TZD’s: pioglitazone and rosiglitazone

↓ insulin resistance (help promote glucose uptake and utilization in adipose tissue) by acting as agonists for PPAR - gamma (peroxisome proliferator activated receptor)

23
Q

which of the TZD’s have more favorable effects on lipids

A
  • pioglitazone > rosigliazone

significant improvements on HDL, TG, LDL particle size and concentration

24
Q

2nd generation sulfonylureas drugs that have replaced the 1st generation

A

2nd generation: glyburide, glipizide, glimepiride

1st generation: chlorpropamide

25
Q

how long does it take to see the effects of TZD’s (-glitazones)

A

weeks or even months (mechanism of action involves gene expression)

26
Q

long term use of metformin ay interfere with ____ (vitamin) absorption

A

B12

27
Q

what is the major AE’s of exenatide?

A
  • acute pancreatitis (exenatide can cause β cell proliferation)
  • should NOT be use din patients with gastroparesis because the drug already slows down gastric emptying
28
Q

how to sulfonylrureas stimulate insulin release from β cells?

A

bind to the SUR1 subunit and block the ATP sensitive K channel in the β cell membrane ultimately leading to exocytosis of insulin

29
Q

_______ is the preferred agent for managing diabetes in pregnant patents

A

human insulin which are the short acting and NPH because they are the least immunogenic; (does not cross placenta unlike other drugs)

30
Q

what are some contraindications of acarbose?

A
  • IBS or any intestinal condition worsened with gas/distention
31
Q

______ (transporter) is responsible for most of glucose reabsorption

A

SGLT-2

32
Q

what is the MOA and effect of metformin?

A
  • it has equal effectiveness of surlfonylureas at ↓ the fasting plasma glucose and HBA1c WITHOUT secreting insulin
  • inhibits gluconoegenesis by reducing gene expression of gluconogeinc enzymes by activation of AMP activated protein kinase
  • AND ↑ insulin mediated glucose utilization in the muscle and liver
33
Q

the decision to transition to insulin in treating type 2 DM should be favorable when HBA1 levels are:

A

> or equal to 8.5%

34
Q

typically insulin is not the intimal therapy in patients with type 2 DM.
what are some scenarios where it can be the initial therapy

A

patients with:

  • significant hyperglycemic symptoms
  • ketonuria
  • HBA1c > 10%
  • random glucose > 300 mg/dL
35
Q

glucagon is used in ______ poisoning

A

β blocker

36
Q

_____ (molecule) stimulates incretin secretion

A

glucose; incretin enhances glucose stimulated insulin secretion but it does NOT enhance insulin secretion on its own (requires glucose in the gut)

enhances glucose dependent insulin secretion

37
Q

in severe hypoglemic patients who have lost consciousness and you cant find an IV line, you can give _____ via ____ (method of administration)

A

glucagon via subcutaneous or IM

38
Q

______ and ______ (drugs) should not be used in patients with gastroparesis

A
  • pramlintide (amylin analog)

- exenatide (incretin analog)

39
Q

glitazones should NOT be use what type of patients?

A

those with Class III/IV HF because it can cause fluid retention and edema and exacerbate CHF

40
Q

________ is the preferred first line drug in treating type 2 DM

A

metformin

41
Q

_______ is given to treat the erectile dysfunction seen in the neuropathy caused by DM

A

sildenalphil (inhibits PDE 5)

42
Q

what drugs would you give to improve the gastroparesis symptoms which can be a complication of diabetes

A
  • metoclopramide
  • erythromycin

boh are pro kinetic agents

43
Q

______ (drug) is an incretin analog

A

exenatide (glucagon-like polypeptide 1 analog)

44
Q

what is the enzyme that degrades human incretin?

A

DPP-4 (dipeptiduyy peptidase IV) and exenatide is resistant to it

45
Q

________ can be given to ↑ the circulating GLP-1 and insulin levels by selectively inhibiting DPP-4

A

sitagliptin

DPP 4 breaks down incretin

46
Q

patents with diabetes and HTN should be given _____

A

ACE inhibitor or ARB

47
Q

sulfonylureas are effective at reducing _____ and _____

A

fasting plasma glucose and HBA1c

PCM Exam 4 (44 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions